Home » Prices » NASDAQ:NTRA

Natera, Inc. stock price

Today's NASDAQ:NTRA chart, history & news

88.97 USD
-1.79 (-1.97%)
Key Stats
Price open 90.63
Previous close 90.76
Market cap 7.60B
Volume 1.16M
Day high
Day low
Year high 91.19
Year low 17.27
Year to date change 162.11%
P/E Ratio -37.23
Company Profile
Insider Information

About Natera, Inc.

Natera is a genetic testing company that operates a CLIA-certified laboratory in San Carlos, California. The company specializes in analyzing microscopic quantities of DNA for reproductive health indications to provide preconception and prenatal genetic testing services to OBGYN physicians and in vitro fertilization centers. In early 2013, the company launched Panorama, a non-invasive prenatal test for pregnant women that screens for the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Other services include tests for preimplantation genetic diagnosis and miscarriage testing to determine the cause of the loss of the pregnancy. A non-invasive paternity test based on Natera’s technology, was brought to market in August 2011 through a partnership with DNA Diagnostics Center , which holds a license to the technology in the United States.

Company information

Company name
Natera Inc
Health Care and Social Assistance
Medical Laboratories

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.